Redcentric Bilan de santé

Santé financière contrôle des critères 1/6

Redcentric possède un total de capitaux propres de £56.8M et une dette totale de £42.7M, ce qui porte son ratio d'endettement à 75.3%. Son actif total et son passif total sont £181.0M et de £124.2M. L'EBIT de Redcentric est £8.7M ce qui fait que son ratio de couverture des intérêts 1.5. Elle dispose de liquidités et de placements à court terme de £4.0M.

Informations clés

75.3%

Ratio d'endettement

UK£42.74m

Dette

Ratio de couverture des intérêts	1.5x
Argent liquide	UK£4.00m
Fonds propres	UK£56.77m
Total du passif	UK£124.20m
Total des actifs	UK£180.96m

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Redcentric plc's (LON:RCN) Price In Tune With Revenues

May 21

Some Confidence Is Lacking In Redcentric plc's (LON:RCN) P/E

Sep 21

Redcentric plc's (LON:RCN) CEO Compensation Is Looking A Bit Stretched At The Moment

Sep 03

An Intrinsic Calculation For Redcentric plc (LON:RCN) Suggests It's 26% Undervalued

Jan 18

Have Insiders Been Selling Redcentric plc (LON:RCN) Shares This Year?

Dec 14

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de RCN ( £42.8M ) ne couvrent pas ses passifs à court terme ( £52.3M ).

Passif à long terme: Les actifs à court terme de RCN ( £42.8M ) ne couvrent pas ses passifs à long terme ( £71.8M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de RCN ( 68.2% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de RCN est passé de 17.6% à 75.3% au cours des 5 dernières années.

Couverture de la dette: La dette de RCN est bien couverte par le flux de trésorerie opérationnel ( 70.8% ).

Couverture des intérêts: Les paiements d'intérêts de RCN sur sa dette ne sont pas bien couverts par l'EBIT ( 1.5 x couverture).

Redcentric Bilan de santé

Santé financière contrôle des critères 1/6

Informations clés

Mises à jour récentes de la santé financière

Recent updates

First half dividend of UK£0.024 announced

First half 2025 earnings released: EPS: UK£0.024 (vs UK£0.001 loss in 1H 2024)

First half dividend of UK£0.024 announced

New major risk - Financial position

Redcentric plc Announces Intention to Pay Interim Dividend, Payable on 25 April 2025

High number of new directors

Redcentric plc Appoints John Radziwill as Non-Executive Director

Redcentric plc Announces Board Changes

CEO & Executive Director exercised options and sold UK£92k worth of stock

Full year 2024 earnings released: UK£0.022 loss per share (vs UK£0.059 loss in FY 2023)

Redcentric plc Recommends Final Dividend for 2024, Expects to Be Paid on 24 January 2025

Redcentric plc Announces Company Secretary Changes

New minor risk - Financial data availability

Redcentric Confirms Early Stages of Discussions with Wiit Regarding a Possible Offer for the Entire Issued and to be Issued Share Capital of Redcentric

Redcentric plc's (LON:RCN) Price In Tune With Revenues

Redcentric plc, Annual General Meeting, Sep 18, 2024

Upcoming dividend of UK£0.012 per share

Redcentric plc Appoints Michelle Senecal De Fonseca as Non-Executive Director, Chair of the Remuneration Committee and Member of the Audit and Nomination Committees

Less than half of directors are independent

Upcoming dividend of UK£0.024 per share at 2.9% yield

First half 2024 earnings released: UK£0.001 loss per share (vs UK£0.039 loss in 1H 2023)

Redcentric plc Declares Interim Dividend for the Six Months Ended 30 September 2023, Payable on 18 April 2024

Redcentric plc Recommends Final Dividend for the Year 2023, Payable on January 19, 2024

Redcentric plc to Report Fiscal Year 2023 Results on Aug 24, 2023

Redcentric plc Reiterates Earnings Guidance for the Fiscal Year 2023

New minor risk - Financial data availability

Consensus forecasts updated

Redcentric plc to Report First Half, 2024 Results on Nov 22, 2023

First half 2023 earnings released: EPS: UK£0.023 (vs UK£0.018 in 1H 2022)

Redcentric plc Announces an Interim Dividend, Payable on 27 January 2023

Consensus forecasts updated

High number of new and inexperienced directors

Redcentric plc Provides Earnings Guidance for the Year 2023

Some Confidence Is Lacking In Redcentric plc's (LON:RCN) P/E

High number of new and inexperienced directors

Consensus forecasts updated

Full year 2022 earnings released: EPS: UK£0.044 (vs UK£0.06 in FY 2021)

Redcentric plc Recommends Final Dividend for the Fiscal Year 2022, Payable on September 16, 2022

Redcentric plc Announces Management Changes

High number of new and inexperienced directors

CEO & Executive Director exercised options and sold UK£255k worth of stock

First half 2022 earnings released: EPS UK£0.017 (vs UK£0.014 in 1H 2021)

Redcentric plc's (LON:RCN) CEO Compensation Is Looking A Bit Stretched At The Moment

Redcentric's (LON:RCN) Earnings Are Of Questionable Quality

Upcoming dividend of UK£0.024 per share

Estimating The Fair Value Of Redcentric plc (LON:RCN)

Senior Independent Non-Executive Director has left the company

What Kind Of Investors Own Most Of Redcentric plc (LON:RCN)?

An Intrinsic Calculation For Redcentric plc (LON:RCN) Suggests It's 26% Undervalued

CEO & Executive Director exercised options and sold UK£107k worth of stock

Redcentric plc has completed a Follow-on Equity Offering in the amount of £38.5 million.

New 90-day low: UK£1.19

Have Insiders Been Selling Redcentric plc (LON:RCN) Shares This Year?

First half 2021 earnings released: EPS UK£0.014

End of Formal Sale Process and Starts Discussions with Interested Parties

New 90-day low: UK£1.23

New 90-day low: UK£1.26

Redcentric plc to Report First Half, 2021 Results on Nov 17, 2020

Price target raised to UK£1.83

Insider recently sold UK£117.4k worth of stock

New 90-day high - UK£1.55

Full year earnings released - UK£0.071 loss per share

New 90-day high - UK£1.53

Redcentric plc to Report Fiscal Year 2020 Final Results on Aug 11, 2020

New 90-day high - UK£1.32

Redcentric plc has completed a Follow-on Equity Offering in the amount of £5.775 million.

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines